Project Grant R43HL142440

The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $1,024,635 project grant to Corvion, Inc. to develop a Totally Implanted Left Ventricular Assist Device (TI-LVAD). The TI-LVAD aims to reduce complications and enhance quality of life for heart failure patients by eliminating the need for a percutaneous driveline and external power supply. The key innovation is a hybrid magnetically levitated blood pump that requires...

This $437,461 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a novel stabilization catheter device for His pacing lead implantation. The goal is to improve the accuracy and ease of His bundle pacing, an emerging alternative cardiac resynchronization therapy (CRT) for heart failure patients. The project aims to refine a deployable suction-tipped lead...

Federal Grant Award Summary Link Medical LLC received a $596,736 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2025, with completion targeted for December 31, 2026. The award funds Phase I development of a novel catheter-based device designed to treat functional mitral valve regurgitation—a condition projected to affect four million Americans by 2030. Link Medical's innovative...

Federal Grant Award Summary Spheric Bio Inc. received a $598,636 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to develop the EMULAATE platform, a patient-specific stroke prevention technology for atrial fibrillation patients. The company will design and develop a minimally-invasive system that assembles fully-soft, personalized implants directly within the patient's body to occlude the left...

Teliatry Inc. received a $768,138 project grant award from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering to develop a minimally invasive, single incision, rechargeable spinal cord stimulation system for chronic pain management. The grant was awarded under the Discovery and Applied Research for Technological Innovations to Improve Human Health program. Through this award, Teliatry will engineer the world's smallest (0.75cc), most cost-effective...

Federal Grant Award Summary Aust Development, LLC received a $313,302 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on September 15, 2025, with completion targeted for August 31, 2026. The company is developing a precision lead delivery platform designed to improve cardiac conduction system (CCS) pacing procedures. The core deliverable is a novel 3D pre-shaped delivery catheter system that...

Federal Grant Award Summary Project Title: A Transcatheter Manufacturing Toolkit for Minimally-Invasive and Patient-Specific Device-Based Stroke Prevention Funding Agency: National Heart, Lung, and Blood Institute (NHLBI) Federal Grant Program: Cardiovascular Diseases Research (CFDA 93.837) Award Amount: $397,034 Award Date: September 1, 2025 Completion Date: July 31, 2027 Awardee: Massachusetts Institute of Technology (MIT) Massachusetts Institute of Technology will develop a transcatheter...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Cutcath LLC a Small Business Technology Transfer (STTR) Phase I Project Grant of $395,306 on July 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports development and early-stage validation of the Cutcath Dissection Septum Cutting Catheter (DSCC), a novel minimally invasive electrosurgical device designated as a breakthrough device by the FDA. The DSCC employs...

Federal Project Grant Award Summary Airalux Medical, Inc. received a $306,872 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 5, 2025, with completion targeted for September 4, 2026. The award funds development and commercialization of a digital incentive spirometry device designed to improve patient adherence and clinical workflow efficiency in post-operative lung complication...

This $7,836,599.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the development of a novel centrifugal left ventricular assist device (LVAD) with wireless power transfer and anti-thrombotic coating technology. The prime awardee, Georgia Tech Research Corporation, will lead the research and development efforts, which include fabricating and characterizing slippery hydrophilic (SLIC) coatings to improve...